EIF4EBP1 and neoplasm: However, after an extended treatment time of 24 h with gemcitabine plus TRAIL we did observe significant resistance of the cells in which 4E-BP1 expression had been silenced (Fig. 5a), suggesting a role for the tumour suppressor protein in the longer-term effects of the combination treatment.